Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma

Hani Al-Halabi, Andre Nantel, A. Klekner, Marie Christine Guiot, Steffen Albrecht, P. Hauser, M. Garami, L. Bognár, Peter Kavan, Noha Gerges, Margret Shirinian, David Roberge, Thierry Muanza, Nada Jabado

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Medulloblastoma (MB) represents approximately 4% of adult brain tumours, and as such is a poorly studied disease. Although many adult MB are treated using paediatric MB protocols, the reported outcomes are inferior to those observed in children. It remains unclear whether biologic differences underlie these clinical observations. We investigated the molecular characteristics of 31 adult MB. Twelve and 19 adult MB were respectively examined using Affymetrix-HG-U133-plus-2.0-genechips and immunohistochemical analyses. 26/31 (84%) of adult MB examined by gene expression and/or immunohistochemical analysis showed evidence of sonic hedgehog (SHH) pathway activation. A comparison of adult and paediatric MB showed that most adult tumours cluster within the SHH-active subgroup of paediatric MB. The preponderance of SHH activity in adult MB tumours was also shown by positive SFRP1 immunostaining in 16/19 adult paraffin-embedded adult MB tumour blocks. A smaller proportion of adult tumours exhibited evidence of WNT pathway activation, as confirmed by nuclear β-catenin staining (9.7%; 3/31). Notably, we found PTCH1 gene mutation in 4/8 samples tested. Similar to children, adult MB has abnormalities in developmental signalling pathways including SHH and WNT. Importantly, we found a preponderance of SHH pathway activation amongst MB tumours in adults. This SHH signature does not appear to correlate with a long-term favourable outcome. Differences in molecular profiles exist between adult and paediatric SHH-driven MB and further investigations are needed to better characterize age-related molecular profiles in this subgroup.

Original languageEnglish
Pages (from-to)229-239
Number of pages11
JournalActa Neuropathologica
Volume121
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Medulloblastoma
Pediatrics
Neoplasms
Catenins
Brain Neoplasms
Paraffin

Keywords

  • Adult medulloblastoma
  • Microarray gene expression profiling
  • Molecular subgroups
  • Sonic hedgehog signalling
  • Targeted therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cellular and Molecular Neuroscience

Cite this

Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. / Al-Halabi, Hani; Nantel, Andre; Klekner, A.; Guiot, Marie Christine; Albrecht, Steffen; Hauser, P.; Garami, M.; Bognár, L.; Kavan, Peter; Gerges, Noha; Shirinian, Margret; Roberge, David; Muanza, Thierry; Jabado, Nada.

In: Acta Neuropathologica, Vol. 121, No. 2, 02.2011, p. 229-239.

Research output: Contribution to journalArticle

Al-Halabi, H, Nantel, A, Klekner, A, Guiot, MC, Albrecht, S, Hauser, P, Garami, M, Bognár, L, Kavan, P, Gerges, N, Shirinian, M, Roberge, D, Muanza, T & Jabado, N 2011, 'Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma', Acta Neuropathologica, vol. 121, no. 2, pp. 229-239. https://doi.org/10.1007/s00401-010-0780-0
Al-Halabi, Hani ; Nantel, Andre ; Klekner, A. ; Guiot, Marie Christine ; Albrecht, Steffen ; Hauser, P. ; Garami, M. ; Bognár, L. ; Kavan, Peter ; Gerges, Noha ; Shirinian, Margret ; Roberge, David ; Muanza, Thierry ; Jabado, Nada. / Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. In: Acta Neuropathologica. 2011 ; Vol. 121, No. 2. pp. 229-239.
@article{b17764a21da64b15a3e2c3355b64cfc5,
title = "Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma",
abstract = "Medulloblastoma (MB) represents approximately 4{\%} of adult brain tumours, and as such is a poorly studied disease. Although many adult MB are treated using paediatric MB protocols, the reported outcomes are inferior to those observed in children. It remains unclear whether biologic differences underlie these clinical observations. We investigated the molecular characteristics of 31 adult MB. Twelve and 19 adult MB were respectively examined using Affymetrix-HG-U133-plus-2.0-genechips and immunohistochemical analyses. 26/31 (84{\%}) of adult MB examined by gene expression and/or immunohistochemical analysis showed evidence of sonic hedgehog (SHH) pathway activation. A comparison of adult and paediatric MB showed that most adult tumours cluster within the SHH-active subgroup of paediatric MB. The preponderance of SHH activity in adult MB tumours was also shown by positive SFRP1 immunostaining in 16/19 adult paraffin-embedded adult MB tumour blocks. A smaller proportion of adult tumours exhibited evidence of WNT pathway activation, as confirmed by nuclear β-catenin staining (9.7{\%}; 3/31). Notably, we found PTCH1 gene mutation in 4/8 samples tested. Similar to children, adult MB has abnormalities in developmental signalling pathways including SHH and WNT. Importantly, we found a preponderance of SHH pathway activation amongst MB tumours in adults. This SHH signature does not appear to correlate with a long-term favourable outcome. Differences in molecular profiles exist between adult and paediatric SHH-driven MB and further investigations are needed to better characterize age-related molecular profiles in this subgroup.",
keywords = "Adult medulloblastoma, Microarray gene expression profiling, Molecular subgroups, Sonic hedgehog signalling, Targeted therapy",
author = "Hani Al-Halabi and Andre Nantel and A. Klekner and Guiot, {Marie Christine} and Steffen Albrecht and P. Hauser and M. Garami and L. Bogn{\'a}r and Peter Kavan and Noha Gerges and Margret Shirinian and David Roberge and Thierry Muanza and Nada Jabado",
year = "2011",
month = "2",
doi = "10.1007/s00401-010-0780-0",
language = "English",
volume = "121",
pages = "229--239",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma

AU - Al-Halabi, Hani

AU - Nantel, Andre

AU - Klekner, A.

AU - Guiot, Marie Christine

AU - Albrecht, Steffen

AU - Hauser, P.

AU - Garami, M.

AU - Bognár, L.

AU - Kavan, Peter

AU - Gerges, Noha

AU - Shirinian, Margret

AU - Roberge, David

AU - Muanza, Thierry

AU - Jabado, Nada

PY - 2011/2

Y1 - 2011/2

N2 - Medulloblastoma (MB) represents approximately 4% of adult brain tumours, and as such is a poorly studied disease. Although many adult MB are treated using paediatric MB protocols, the reported outcomes are inferior to those observed in children. It remains unclear whether biologic differences underlie these clinical observations. We investigated the molecular characteristics of 31 adult MB. Twelve and 19 adult MB were respectively examined using Affymetrix-HG-U133-plus-2.0-genechips and immunohistochemical analyses. 26/31 (84%) of adult MB examined by gene expression and/or immunohistochemical analysis showed evidence of sonic hedgehog (SHH) pathway activation. A comparison of adult and paediatric MB showed that most adult tumours cluster within the SHH-active subgroup of paediatric MB. The preponderance of SHH activity in adult MB tumours was also shown by positive SFRP1 immunostaining in 16/19 adult paraffin-embedded adult MB tumour blocks. A smaller proportion of adult tumours exhibited evidence of WNT pathway activation, as confirmed by nuclear β-catenin staining (9.7%; 3/31). Notably, we found PTCH1 gene mutation in 4/8 samples tested. Similar to children, adult MB has abnormalities in developmental signalling pathways including SHH and WNT. Importantly, we found a preponderance of SHH pathway activation amongst MB tumours in adults. This SHH signature does not appear to correlate with a long-term favourable outcome. Differences in molecular profiles exist between adult and paediatric SHH-driven MB and further investigations are needed to better characterize age-related molecular profiles in this subgroup.

AB - Medulloblastoma (MB) represents approximately 4% of adult brain tumours, and as such is a poorly studied disease. Although many adult MB are treated using paediatric MB protocols, the reported outcomes are inferior to those observed in children. It remains unclear whether biologic differences underlie these clinical observations. We investigated the molecular characteristics of 31 adult MB. Twelve and 19 adult MB were respectively examined using Affymetrix-HG-U133-plus-2.0-genechips and immunohistochemical analyses. 26/31 (84%) of adult MB examined by gene expression and/or immunohistochemical analysis showed evidence of sonic hedgehog (SHH) pathway activation. A comparison of adult and paediatric MB showed that most adult tumours cluster within the SHH-active subgroup of paediatric MB. The preponderance of SHH activity in adult MB tumours was also shown by positive SFRP1 immunostaining in 16/19 adult paraffin-embedded adult MB tumour blocks. A smaller proportion of adult tumours exhibited evidence of WNT pathway activation, as confirmed by nuclear β-catenin staining (9.7%; 3/31). Notably, we found PTCH1 gene mutation in 4/8 samples tested. Similar to children, adult MB has abnormalities in developmental signalling pathways including SHH and WNT. Importantly, we found a preponderance of SHH pathway activation amongst MB tumours in adults. This SHH signature does not appear to correlate with a long-term favourable outcome. Differences in molecular profiles exist between adult and paediatric SHH-driven MB and further investigations are needed to better characterize age-related molecular profiles in this subgroup.

KW - Adult medulloblastoma

KW - Microarray gene expression profiling

KW - Molecular subgroups

KW - Sonic hedgehog signalling

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=79451469572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79451469572&partnerID=8YFLogxK

U2 - 10.1007/s00401-010-0780-0

DO - 10.1007/s00401-010-0780-0

M3 - Article

C2 - 21107850

AN - SCOPUS:79451469572

VL - 121

SP - 229

EP - 239

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 2

ER -